<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
</B></FONT><B><FONT STYLE="font-size: 10pt">WASHINGTON, D.C. 20549</FONT></B><FONT STYLE="font-size: 10pt"> </FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">PURSUANT TO SECTION 13
OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">DATE OF REPORT (DATE OF
EARLIEST EVENT REPORTED):&nbsp;<B> February 14, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 18pt"><B><U>Skinny
Nutritional Corp.<BR>
</U></B></FONT><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">COMMISSION FILE NUMBER<B>:&nbsp;&nbsp;<U>0-51313</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Nevada</TD>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">88-0314792</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(State or other jurisdiction of incorporation or organization)</TD>
    <TD STYLE="font-size: 10pt; text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%; font-size: 10pt; font-weight: bold; text-align: center">Three Bala Plaza East, Suite 101</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Bala Cynwyd, PA 19004</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(Address and zip code of principal executive offices)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 10pt"><B><U>(610)
784-2000<BR>
</U></B>(Registrant&rsquo;s telephone number, including area code </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">CHECK THE APPROPRIATE BOX BELOW IF THE FORM
8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT></TD><TD>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT></TD><TD>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT></TD><TD>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT></TD><TD>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><BR>
<BR STYLE="mso-special-character: line-break">
<BR STYLE="mso-special-character: line-break">
</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 1.01</B></TD><TD STYLE="text-align: justify"><B>Entry into
                                                                                   a Material Definitive Agreement.</B></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">Skinny
Nutritional Corp. (&ldquo;<U>Skinny</U>&rdquo; or the &ldquo;<U>Company</U>&rdquo;) entered into an exclusive
Product Manufacturing and Distribution Agreement (the &ldquo;<U>Agreement</U>&rdquo;) with CliffStar, LLC
(the &ldquo;<U>Manufacturer</U>&rdquo;), a subsidiary of Cott Corporation, on February 14, 2012, which is effective as of
January 31, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">Subject
to the terms and conditions of the Agreement, Skinny granted Manufacturer <FONT STYLE="color: black">an exclusive, non-transferable,
limited right</FONT> and license to use the Skinny Water trademark, including the right to sub-license, solely upon and in connection
with the development, production, processing, packaging, storage, distribution, and sale of the Company&rsquo;s Skinny Water products
and other products which it may develop in the future. The territory covered by the Agreement is the United States and Canada.
The Agreement also provides that in the event that Skinny desires to distribute products outside of the territory, Manufacturer
shall have a right of first refusal to negotiate in good faith amendments to the Agreement as may be necessary or appropriate
for Manufacturer to produce and/or distribute products in such additional locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">Under
the Agreement, Skinny shall be solely responsible for all marketing, promotion, customer relations (except and to the extent specifically
provided otherwise in the Agreement) and other activities related to the sale of the products. Further, under the Agreement, the
parties intend for Manufacturer to become responsible for sourcing, purchasing, maintaining inventory and otherwise providing
all ingredients required for the manufacture of the products following a transition period. However, until such time as Manufacturer
is prepared to source directly any or all other ingredients of the products, Manufacturer will continue to obtain such ingredients
from Skinny. Additionally, the parties intend for Manufacturer to become responsible for providing all packaging materials, including
but not limited to labels, necessary for the production and shipment of the products following a transition period. Until such
time as Manufacturer is prepared to source directly any or all packaging materials for the products, it will obtain such packaging
materials from Skinny and Skinny will source the product containers at its sole expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">The
Agreement also provides that in connection with sales to Wal-Mart only (unless the parties otherwise expressly agree in writing)
Manufacturer shall be responsible for the delivery of Products, invoicing and collection of receivables from Wal-Mart and shall
pay to Skinny royalties derived from such sales. Skinny will remain be responsible for all other product distribution and sales
at its sole cost and expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">The
Agreement commenced as of the effective date of January 31, 2012 and will continue until terminated by either party on 36 months
prior written notice. However, either party may sooner terminate the agreement upon written notice, with a right to cure, if the
other party is in default under the Agreement. Further, the Company has the right to immediately terminate the Agreement upon
written notice in the event of a material breach, as defined in the Agreement, by Manufacturer. In the event of a termination
for default or material breach, the Company will buy from Manufacturer all finished product inventory and concentrate. In addition,
either party may terminate the Agreement upon the occurrence of any event or circumstance that it considers to constitute an imminent
danger to the health and safety of the public. If Manufacturer terminates the Agreement based on such reason, Skinny shall also
be required to purchase finished product inventory and concentrate. Further, Manufacturer may dispose or sell product on hand
during a 90 day period following the expiration of the Agreement at the end of its term. The agreement provides for customary
covenants by both parties regarding insurance and indemnification matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">The
foregoing summary of the Agreement and the transactions contemplated thereby does not purport to be complete and is subject to,
and is qualified in its entirety by, the Agreement, which the Company anticipates will be filed, subject to a request for confidential
treatment for portions thereof, as an exhibit to the Company&rsquo;s annual report on Form 10-K for the year ending December&nbsp;31,
2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify"></P>

</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 8.01</B></TD><TD STYLE="text-align: justify"><B>Other
                                                                                          Events.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">On
February 21, 2012, the Company issued a press release announcing its entry into the Agreement. A copy of this press release is
attached as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibit.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 1in; text-indent: 0in; text-align: justify">The following exhibits are attached to this Form 8-K:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">(d)</TD>
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-decoration: underline">Exhibit No.</TD>
    <TD STYLE="width: 73%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-decoration: underline">Description</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">99.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Press Release</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 42%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 56%; font-weight: bold">Skinny Nutritional Corp.</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: windowtext 1pt solid">By: &nbsp;/s/ Michael Salaman</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Michael Salaman</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR>
    <TD>&nbsp;Date: February 21, 2012</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>EXHIBIT INDEX</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: baseline">
    <TD STYLE="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">Exhibit</TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">Number</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">Description</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: baseline">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">99.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Press Release&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->




<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v303196_8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 20581}]
{"company-data": {"conformed-name": "Skinny Nutritional Corp.", "cik": "0001176325", "assigned-sic": "5141", "irs-number": "233100268", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51313", "film-number": "12627270"}, "business-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004", "phone": "610-784-2000"}, "mail-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004"}, "former-company": {"former-conformed-name": "CREATIVE ENTERPRISES INTERNATIONAL INC", "date-changed": "20020625"}}
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13
OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF
EARLIEST EVENT REPORTED):
February 14, 2012
Skinny
Nutritional Corp.
(Exact name of registrant as specified in its charter)
COMMISSION FILE NUMBER
:
0-51313
Nevada
88-0314792
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
Three Bala Plaza East, Suite 101
Bala Cynwyd, PA 19004
(Address and zip code of principal executive offices)
(610)
784-2000
(Registrant's telephone number, including area code
CHECK THE APPROPRIATE BOX BELOW IF THE FORM
8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01
Entry into
                                                                                   a Material Definitive Agreement.
Skinny
Nutritional Corp. ("
Skinny
" or the "
Company
") entered into an exclusive
Product Manufacturing and Distribution Agreement (the "
Agreement
") with CliffStar, LLC
(the "
Manufacturer
"), a subsidiary of Cott Corporation, on February 14, 2012, which is effective as of
January 31, 2012.
Subject
to the terms and conditions of the Agreement, Skinny granted Manufacturer
an exclusive, non-transferable,
limited right
and license to use the Skinny Water trademark, including the right to sub-license, solely upon and in connection
with the development, production, processing, packaging, storage, distribution, and sale of the Company's Skinny Water products
and other products which it may develop in the future. The territory covered by the Agreement is the United States and Canada.
The Agreement also provides that in the event that Skinny desires to distribute products outside of the territory, Manufacturer
shall have a right of first refusal to negotiate in good faith amendments to the Agreement as may be necessary or appropriate
for Manufacturer to produce and/or distribute products in such additional locations.
Under
the Agreement, Skinny shall be solely responsible for all marketing, promotion, customer relations (except and to the extent specifically
provided otherwise in the Agreement) and other activities related to the sale of the products. Further, under the Agreement, the
parties intend for Manufacturer to become responsible for sourcing, purchasing, maintaining inventory and otherwise providing
all ingredients required for the manufacture of the products following a transition period. However, until such time as Manufacturer
is prepared to source directly any or all other ingredients of the products, Manufacturer will continue to obtain such ingredients
from Skinny. Additionally, the parties intend for Manufacturer to become responsible for providing all packaging materials, including
but not limited to labels, necessary for the production and shipment of the products following a transition period. Until such
time as Manufacturer is prepared to source directly any or all packaging materials for the products, it will obtain such packaging
materials from Skinny and Skinny will source the product containers at its sole expense.
The
Agreement also provides that in connection with sales to Wal-Mart only (unless the parties otherwise expressly agree in writing)
Manufacturer shall be responsible for the delivery of Products, invoicing and collection of receivables from Wal-Mart and shall
pay to Skinny royalties derived from such sales. Skinny will remain be responsible for all other product distribution and sales
at its sole cost and expense.
The
Agreement commenced as of the effective date of January 31, 2012 and will continue until terminated by either party on 36 months
prior written notice. However, either party may sooner terminate the agreement upon written notice, with a right to cure, if the
other party is in default under the Agreement. Further, the Company has the right to immediately terminate the Agreement upon
written notice in the event of a material breach, as defined in the Agreement, by Manufacturer. In the event of a termination
for default or material breach, the Company will buy from Manufacturer all finished product inventory and concentrate. In addition,
either party may terminate the Agreement upon the occurrence of any event or circumstance that it considers to constitute an imminent
danger to the health and safety of the public. If Manufacturer terminates the Agreement based on such reason, Skinny shall also
be required to purchase finished product inventory and concentrate. Further, Manufacturer may dispose or sell product on hand
during a 90 day period following the expiration of the Agreement at the end of its term. The agreement provides for customary
covenants by both parties regarding insurance and indemnification matters.
The
foregoing summary of the Agreement and the transactions contemplated thereby does not purport to be complete and is subject to,
and is qualified in its entirety by, the Agreement, which the Company anticipates will be filed, subject to a request for confidential
treatment for portions thereof, as an exhibit to the Company's annual report on Form 10-K for the year ending December 31,
2011.
Item 8.01
Other
                                                                                          Events.
On
February 21, 2012, the Company issued a press release announcing its entry into the Agreement. A copy of this press release is
attached as Exhibit 99.1.
Item 9.01
Financial Statements and Exhibit.
The following exhibits are attached to this Form 8-K:
(d)
Exhibit No.
Description
99.1
Press Release
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
Skinny Nutritional Corp.
By:  /s/ Michael Salaman
Name: Michael Salaman
Title:   Chief Executive Officer
Date: February 21, 2012
EXHIBIT INDEX
Exhibit
Number
Description
99.1
Press Release